Format

Send to

Choose Destination
Diabetes Care. 2010 Aug;33(8):1699-705. doi: 10.2337/dc09-2302. Epub 2010 Apr 27.

Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes.

Author information

1
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. j.beulens@umcutrecht.nl

Abstract

OBJECTIVE:

To investigate whether dietary phylloquinone and menaquinones intakes are related to risk of type 2 diabetes.

RESEARCH DESIGN AND METHODS:

We used data from a prospective cohort study in 38,094 Dutch men and women, aged 20-70 years. Dietary phylloquinone and menaquinones intakes were assessed using a validated food frequency questionnaire. Diabetes case patients were ascertained mainly via self-report and verified against medical records.

RESULTS:

During 10.3 years of follow-up, 918 incident cases of diabetes were documented. In a multivariate model adjusting for diabetes risk factors and dietary factors, phylloquinone intake tended to be associated (P = 0.08) with a reduced risk of type 2 diabetes with a hazard ratio (HR) of 0.81 (95% CI 0.66-0.99) for the highest versus the lowest quartile. For menaquinones intake, a linear, inverse association (P = 0.038) with risk of type 2 diabetes was observed with an HR of 0.93 (0.87-1.00) for each 10-microg increment in the multivariate model.

CONCLUSIONS:

This study shows that both phylloquinone and menaquinones intakes may be associated with a reduced risk of type 2 diabetes.

PMID:
20424220
PMCID:
PMC2909045
DOI:
10.2337/dc09-2302
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center